1171891-19-2 Usage
Uses
Used in Organic Synthesis:
N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)propionamide is used as a reagent in organic synthesis for its potential role in cross-coupling reactions and other transformations facilitated by boron-containing reagents. The dioxaborolan-2-yl group's reactivity and stability make it a promising candidate for the synthesis of complex organic molecules.
Used in Medicinal Chemistry and Drug Discovery:
In the field of medicinal chemistry, N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)propionamide is used as a starting material or intermediate for the development of new pharmaceuticals. N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)propionamide's boron-containing structure may offer unique properties that could be harnessed in the creation of novel therapeutic agents for a range of diseases, given the known potential of boron compounds in medicinal applications.
Used in Research and Development:
N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)propionamide is utilized in research and development for exploring its full potential in various scientific and industrial fields. Further study may reveal additional applications and optimize its use in creating innovative products and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1171891-19-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,1,8,9 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1171891-19:
(9*1)+(8*1)+(7*7)+(6*1)+(5*8)+(4*9)+(3*1)+(2*1)+(1*9)=162
162 % 10 = 2
So 1171891-19-2 is a valid CAS Registry Number.
1171891-19-2Relevant academic research and scientific papers
Pyrrolopyrimidines and Pyrrolopyridines
-
Page/Page column 50-52, (2009/07/25)
Compounds of formula I in free or salt or solvate form, wherein X, T1, T3 and T4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
